Sameh Tawfik

Array ( [id] => 10006875 [patent_doc_number] => 09050373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/800376 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7071 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12800376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518791 [patent_doc_number] => 20100216982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'POLYCYCLIC SUGAR SURROGATE-CONTAINING OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATION' [patent_app_type] => utility [patent_app_number] => 12/774566 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 37378 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216982.pdf [firstpage_image] =>[orig_patent_app_number] => 12774566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834717 [patent_doc_number] => 08450473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Compositions and methods for therapy of macular degeneration' [patent_app_type] => utility [patent_app_number] => 13/266219 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5915 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237003 [patent_doc_number] => 20100267815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'PFKFB4 Inhibitors And Methods Of Using The Same' [patent_app_type] => utility [patent_app_number] => 12/761773 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6515 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267815.pdf [firstpage_image] =>[orig_patent_app_number] => 12761773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6502898 [patent_doc_number] => 20100286362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Mammalian MDM2 Binding Proteins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/759906 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6201 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286362.pdf [firstpage_image] =>[orig_patent_app_number] => 12759906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732656 [patent_doc_number] => 20130078225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'Method for Modulating MicroRNA Content in Living Beings and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/641074 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11514 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6273295 [patent_doc_number] => 20100255545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'INTEGRATED - LIGAND-RESPONSIVE MICRORNAS' [patent_app_type] => utility [patent_app_number] => 12/753778 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16544 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255545.pdf [firstpage_image] =>[orig_patent_app_number] => 12753778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276366 [patent_doc_number] => 20100256219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Small interfering DNA (siDNA) oligonucleotides as an antiviral agent against Herpes virus infections' [patent_app_type] => utility [patent_app_number] => 12/748897 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6618 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256219.pdf [firstpage_image] =>[orig_patent_app_number] => 12748897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772624 [patent_doc_number] => 08426581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'RNA interference mediated inhibition of the FCεR1α gene' [patent_app_type] => utility [patent_app_number] => 13/256095 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41737 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096400 [patent_doc_number] => 20110003378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'MULTIPLE PROMOTER EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS' [patent_app_type] => utility [patent_app_number] => 12/723466 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19564 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003378.pdf [firstpage_image] =>[orig_patent_app_number] => 12723466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8005697 [patent_doc_number] => 08084249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Vector' [patent_app_type] => utility [patent_app_number] => 12/714264 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 21543 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084249.pdf [firstpage_image] =>[orig_patent_app_number] => 12714264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234843 [patent_doc_number] => 20100266547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF INTERFERON-RESISTANT TUMORS' [patent_app_type] => utility [patent_app_number] => 12/706625 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11599 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266547.pdf [firstpage_image] =>[orig_patent_app_number] => 12706625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8339702 [patent_doc_number] => 08241623 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-08-14 [patent_title] => 'Protease sensitivity expression system' [patent_app_type] => utility [patent_app_number] => 12/703158 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 11223 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12703158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032905 [patent_doc_number] => 09074212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'RNAi inhibition of alpha-ENaC expression' [patent_app_type] => utility [patent_app_number] => 12/683146 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38420 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12683146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6379903 [patent_doc_number] => 20100316615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Antisense Oligonucleotides Against VR1' [patent_app_type] => utility [patent_app_number] => 12/645625 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10269 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316615.pdf [firstpage_image] =>[orig_patent_app_number] => 12645625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231435 [patent_doc_number] => 20100184670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'ANTISENSE COMPOSITIONS AND METHODS FOR MODULATING CONTACT HYPERSENSITIVITY OR CONTACT DERMATITIS' [patent_app_type] => utility [patent_app_number] => 12/641159 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25687 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184670.pdf [firstpage_image] =>[orig_patent_app_number] => 12641159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987765 [patent_doc_number] => 20110098460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'SiRNA Useful to Suppress expression of eIF-5A1' [patent_app_type] => utility [patent_app_number] => 12/640148 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 33726 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098460.pdf [firstpage_image] =>[orig_patent_app_number] => 12640148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323056 [patent_doc_number] => 20100113761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'siRNA targeting beta secretase (BACE)' [patent_app_type] => utility [patent_app_number] => 12/653402 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34645 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113761.pdf [firstpage_image] =>[orig_patent_app_number] => 12653402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6583138 [patent_doc_number] => 20100291188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Periostin Inhibitory Compositions for Myocardial Regeneration, Methods of Delivery, and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 12/631655 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19924 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291188.pdf [firstpage_image] =>[orig_patent_app_number] => 12631655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10104052 [patent_doc_number] => 09139827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Polyvalent RNA-nanoparticle compositions' [patent_app_type] => utility [patent_app_number] => 12/625537 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15489 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12625537 [rel_patent_id] =>[rel_patent_doc_number] =>)